Back to Trades
Quinlan Paul T
General CounselCIK 0001333277
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 17
- Companies
- 1
- Active
- 2026
Quinlan Paul T, General Counsel, has filed 6 SEC reports (2026), all concentrated in Oruka Therapeutics, Inc. (ORKA), totaling $13.4M in disclosed volume. Weighing $0 bought versus $7.4M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Oct 20 | ORKA Oruka Therapeutics, Inc. | Quinlan Paul T | General Counsel | Sell | $706.7K |
| Sep 21 | ORKA Oruka Therapeutics, Inc. | Quinlan Paul T | General Counsel | Sell | $936.4K |
| Sep 15 | ORKA Oruka Therapeutics, Inc. | Quinlan Paul T | General Counsel | Sell | $99.4K |
| Aug 14 | ORKA Oruka Therapeutics, Inc. | Quinlan Paul T | General Counsel | Sell | $5.6M |
| Jun 15 | ORKA Oruka Therapeutics, Inc. | Quinlan Paul T | General Counsel | Sell | $51.1K |
| Jan 23 | ORKA Oruka Therapeutics, Inc. | Quinlan Paul T | General Counsel | Grant | $4.5M |
6 filings